Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-21-018416

Chief Financial Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Estepan Ian Michael · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-03 Grant or award : show line 1 in the form +15,000 29,042 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-03 Grant or award : show line 2 in the form Stock Option (right to buy) +60,000 60,000 D
Loading xslF345X03/doc4.xml…